Downregulating SOCS3 with siRNA ameliorates insulin signaling and glucose metabolism in hepatocytes of IUGR rats with catch-up growth (Q87369430)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Downregulating SOCS3 with siRNA ameliorates insulin signaling and glucose metabolism in hepatocytes of IUGR rats with catch-up growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

7

Katherine Cianflone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Juan Ye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ruidan Zheng

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Qun Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Lihong Liao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yanqin Ying

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Huiling Lu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Qin Ning

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Xiaoping Luo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

24 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

550-559

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity.

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Intrauterine growth restriction and developmental programming of the metabolic syndrome: a critical appraisal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Fetal origins of adult diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Causes of intrauterine growth restriction and the postnatal development of the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Insulin sensitivity and secretion are related to catch-up growth in small-for-gestational-age infants at age 1 year: results from a prospective cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

SOCS proteins causing trouble in insulin action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

SOCS3 is essential in the regulation of fetal liver erythropoiesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

The dual function of hepatic SOCS3 in insulin resistance in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Inhibition of SOCS-3 in adipocytes of rats with diet-induced obesity increases leptin-mediated fatty acid oxidation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

The influence of down-regulation of suppressor of cellular signaling proteins by RNAi on glucose transport of intrauterine growth retardation rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Intrauterine growth restriction: definition and etiology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Comparison of two models of intrauterine growth restriction for early catch-up growth and later development of glucose intolerance and obesity in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Hepatic insulin resistance, metabolic syndrome and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Hepatic insulin resistance precedes the development of diabetes in a model of intrauterine growth retardation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Novel concepts in insulin regulation of hepatic gluconeogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Disruption of IRS-2 causes type 2 diabetes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Insulin signalling and the regulation of glucose and lipid metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Role of the liver in the control of carbohydrate and lipid homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

Chapter 4 Preparation of Isolated Rat Liver Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2012.123

31 March 2020

Identifiers

DOI

10.1038/PR.2012.123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007031%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference